DOLAUT MONO*8CER MED 14MG

DOLAUT MONO 14 mg
Medicated plaster

What it is and what it is used for
DOLAUT MONO is a medicated plaster based on piroxicam, a non-steroidal anti-inflammatory drug with a marked anti-inflammatory and analgesic action. The pharmacological effects are mainly due to the inhibition of prostaglandin synthetase.
The activity of the active ingredient administered topically in various models of acute and chronic inflammation occurs even in the presence of reduced plasma levels.

DOLAUT MONO is indicated for the treatment of painful and inflammatory conditions of a rheumatic and traumatic nature affecting joints, muscles, tendons and ligaments.

What you need to know before taking the medicine
When it should not be used:
- Hypersensitivity to the active substance or to any of the excipients
- On open wounds or lesions
- Avoid contact with eyes and mucous membranes
- In case of a history of hypersensitivity reactions (asthma, allergic rhinitis, skin rashes and anaphylactic reactions) or gastrointestinal bleeding due to anti-inflammatory drugs
- In the presence of active peptic ulcer, in patients with bronchial asthma or on anticoagulant therapy
- Pregnancy and breastfeeding
- Children under 12 years of age

Warnings and precautions
Analgesics, antipyretics, non-steroidal anti-inflammatory drugs, including piroxicam, can cause hypersensitivity reactions, potentially serious even in subjects not previously exposed to this type of drug.
DOLAUT MONO should be used with great caution and under medical prescription in the elderly, in subjects with chronic bronchitis, allergic rhinitis or inflammation of the nasal mucosa (in whom asthmatic attacks or severe inflammatory reactions of the skin and mucosa are more frequent), in patients with a history of gastrointestinal diseases (such as gastrointestinal ulcer, ulcerative colitis or Crohn's disease), in patients with a history of gastrointestinal bleeding not secondary to NSAID administration or with other bleeding disorders, with liver or kidney dysfunction or with heart failure. To avoid any phenomena of hypersensitivity or photosensitization, avoid exposure to direct sunlight.

If you develop a rash or skin symptoms, you should immediately stop taking DOLAUT MONO, consult a doctor immediately and inform them that you are taking this medicine.

Possible side effects
Like all medicines, DOLAUT MONO 14 mg medicated plaster can cause side effects, although not everyone experiences them.
The use of DOLAUT MONO can lead to the appearance of allergic skin reactions, erythema, itching, irritation, burning, contact dermatitis, numbness and tingling at the application site;
with this type of medicine, cases of extensive and severe dermatological lesions such as urticaria, Quincke's edema, erythema multiforme have been reported.
Photosensitivity skin reactions and more extensive and more severe reactions, including asthma attacks, are possible.
Systemic undesirable reactions following the topical use of piroxicam are unlikely; since the plasma levels obtained are lower than those measured after systemic administration but very variable from individual to individual, it is not possible to exclude, especially in the case of prolonged therapies beyond the recommended period and non-observance of contraindications and warnings, the appearance of systemic undesirable effects, especially at the gastrointestinal level.
In case of local or general undesirable effects, it is necessary to interrupt the treatment and consult a doctor to establish appropriate therapy.

Frequency not known
Fixed drug eruption (may appear as round or oval spots of redness and swelling of the skin), blisters (urticaria), itching

Following the instructions in the package leaflet reduces the risk of side effects.

The described side effects are generally temporary. However, if they occur, it is advisable to consult your Doctor or Pharmacist.

If any of the side effects get worse, or if you notice any side effects not listed in this leaflet, tell your doctor or pharmacist.